Get the Stockscreener App
0.7809
6.29%
0.0462
After Hours:
.78
-0.0009
-0.12%
Nuwellis Inc stock is traded at $0.7809, with a volume of 221.32K.
It is up +6.29% in the last 24 hours and down -58.46% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$0.7347
Open:
$0.75
24h Volume:
221.32K
Relative Volume:
0.07
Market Cap:
$2.48M
Revenue:
$8.77M
Net Income/Loss:
$-19.05M
P/E Ratio:
-0.000348
EPS:
-2243.7675
Net Cash Flow:
$-11.60M
1W Performance:
-12.15%
1M Performance:
-58.46%
6M Performance:
-98.57%
1Y Performance:
-99.54%
1-Day Range:
$0.7422
$0.7823
1-Week Range:
$0.7112
$0.883
52-Week Range:
$0.7112
$183.05
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
0.7809 | 3.56M | 8.77M | -19.05M | -11.60M | -2,243.77 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Nuwellis Inc (NASDAQ: NUWE) Share Price, NUWE Stock News, NUWE Share Price & Updates - Kalkine
Nuwellis, Inc. Announces First Quarter 2026 F - Moomoo
NUWE|Nuwellis Inc|Price:0.889|Chg%:-0.100 - TradingKey
Nuwellis, Inc. SEC Filing (Aug 27, 2026) - Stock Titan
NUWE Stock Slides As Nuwellis Strikes New Pediatric Deals - timothysykes.com
Nuwellis posts updated investor presentation highlighting Aquadex growth, 20% H1 revenue rise - TradingView
Biotech Pre-Market Movers: NUWE, SMMT Surge; SYRE, PFSA Sink - rttnews.com
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com Nigeria
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical - The Manila Times
Nuwellis enters co-promotion deal for cardiac monitoring device - Investing.com
NUWE Should I Buy - Intellectia AI
Nuwellis study shows epoprostenol safe for pediatric Aquadex therapy - scanx.trade
Nuwellis (NUWE) Momentum: Posts a 4.27% Loss to $1.12; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingAdvance Decline Line - vinanet.vn
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotSuperTrend - dars.gov.et
Armistice Capital (NUWE) trims Nuwellis ownership to a 4.99% disclosed stake - Stock Titan
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base Expands - GuruFocus
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ... - Yahoo Finance UK
Nuwellis Posts 14% Revenue Jump in Q2 2026, Misses on EPS - AlphaStreet
Nuwellis, Inc. (NASDAQ: NUWE) lifts Q2 2026 revenue and margin but stays unprofitable - Stock Titan
Nuwellis Reports Q2 2026: Revenue $2.0M, Gross Margin 76%, Net Loss $4.8M - TradingView
Nuwellis (NASDAQ: NUWE) boosts revenue, flags going concern and Nasdaq risks - Stock Titan
Nuwellis Q2 Results: Revenue Up 14% YoY, Gross Margin Expands To 76% - scanx.trade
Earnings call transcript: Nuwellis posts higher revenue in Q2 2026 as loss narrows - Investing.com Nigeria
NUWE: Q2 revenue up 14% year-over-year, gross margin at 76%, and net loss reduced to $4.8 million - TradingView
Transcript : Nuwellis, Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
Nuwellis Q2 2026 Earnings Call Transcript - Benzinga
Q2 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - marketscreener.com
BRIEF-Nuwellis Q2 EPS USD -26.64 - TradingView
Press Release: Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - Moomoo
Nuwellis, Inc. (NUWE) stock price, news, quote and history - Yahoo Finance UK
NUWE Q2'26 Earnings: EPS estimate is (23.80) USD - TradingView
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Nuwellis Announces Digital Transformation Program for Aquadex SmartFlow System with Philips Capsule Integration - Quiver Quantitative
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface - The Manila Times
Nuwellis Announces Digital Transformation of the Aquadex Smartflow System with Ehr Connectivity and Enhanced User Interface - marketscreener.com
NUWE Q1 2026 Earnings: Massive EPS Miss Triggers 4.7% Share DeclineEPS Growth Report - vinanet.vn
Q&A: Building the next generation of cardiorenal care: An interview with Nuwellis - Digital Journal
Certain Common Stock of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.com
Orca Capital (NUWE) discloses 7.0% Nuwellis ownership and warrant blocker - Stock Titan
Certain Stock Options of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.com
Nuwellis appoints Dale Brady as principal R&D engineer By Investing.com - Investing.com UK
Nuwellis, Inc. (NUWE) investors detail 4.7% warrant-based ownership stake - Stock Titan
Nuwellis appoints Dale Brady as principal R&D engineer - Investing.com
Medical Device Engineer With More Than 25 Years' Experience Joins Nuwellis - Stock Titan
NUWE Q2'26 Earnings: revenue estimate is 2.42M USD - tradingview.com
Nuwellis appoints Dale Brady principal R&D engineer - Bitget
Nuwellis (NUWE) investor reports 6.2% stake via shares and capped warrants - Stock Titan
Nuwellis, Inc. Announces Appointment of Dale Brady to Principal R&D Engineer - marketscreener.com
NUWE Stock Whipsaws As Growth, Patents And Volatility Collide - StocksToTrade
Nuwellis plans to expand Aquadex system capabilities By Investing.com - Investing.com South Africa
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):